OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Succinate‐GPR‐91 receptor signalling is responsible for nonalcoholic steatohepatitis‐associated fibrosis: Effects of DHA supplementation
Xuejing Liu, Li Xie, Kuo Du, et al.
Liver International (2020) Vol. 40, Iss. 4, pp. 830-843
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Rethinking succinate: an unexpected hormone-like metabolite in energy homeostasis
Sonia Fernández‐Veledo, Victòria Ceperuelo‐Mallafré, Joan Vendrell
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 9, pp. 680-692
Closed Access | Times Cited: 67

Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis
Jinge Zhou, Lei Sun, Li Liu, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 175-186
Closed Access | Times Cited: 64

Cancer-derived extracellular succinate: a driver of cancer metastasis
Cheng-Chin Kuo, Jing-Yiing Wu, Kenneth K. Wu
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 46

GPCRs involved in metabolic diseases: pharmacotherapeutic development updates
Hongchuan Jin, Hui Chen, Li Xie, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 7, pp. 1321-1336
Closed Access | Times Cited: 11

The emerging role of metabolism in fibrosis
John Henderson, Steven O’Reilly
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 8, pp. 639-653
Closed Access | Times Cited: 51

Pharmaceutical targeting of succinate dehydrogenase in fibroblasts controls bleomycin-induced lung fibrosis
Ziwen Wang, Long Chen, Yu Huang, et al.
Redox Biology (2021) Vol. 46, pp. 102082-102082
Open Access | Times Cited: 50

Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis
Yong‐Yu Yang, Li Xie, Ning‐Ping Zhang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 5, pp. 1180-1190
Open Access | Times Cited: 36

Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD
Anna Marsal-Beltran, Adrià Rodríguez-Castellano, Brenno Astiarraga, et al.
Metabolism (2023) Vol. 145, pp. 155630-155630
Open Access | Times Cited: 17

Type 2 diabetes and succinate: unmasking an age-old molecule
Sonia Fernández‐Veledo, Anna Marsal-Beltran, Joan Vendrell
Diabetologia (2024) Vol. 67, Iss. 3, pp. 430-442
Open Access | Times Cited: 6

Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis
Curtis C. Hughey, Patrycja Puchalska, Peter A. Crawford
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 11, pp. 159209-159209
Closed Access | Times Cited: 22

Extracellular Succinate: A Physiological Messenger and a Pathological Trigger
Kenneth K. Wu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11165-11165
Open Access | Times Cited: 13

JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway
Li Zhang, Yong‐Yu Yang, Li Xie, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 4

G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment
Ming Yang, Chunye Zhang
World Journal of Gastroenterology (2021) Vol. 27, Iss. 8, pp. 677-691
Open Access | Times Cited: 30

Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases
Chang Liu, Yu‐Li Wang, Yongyu Yang, et al.
The FASEB Journal (2021) Vol. 35, Iss. 10
Closed Access | Times Cited: 28

GPR91, a critical signaling mechanism in modulating pathophysiologic processes in chronic illnesses
Xinyi Li, Li Xie, Xiangli Qu, et al.
The FASEB Journal (2020) Vol. 34, Iss. 10, pp. 13091-13105
Open Access | Times Cited: 30

G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes
Xiaoli Wei, Fan Yin, Miaomiao Wu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 3, pp. 1128-1144
Open Access | Times Cited: 17

Metabolic fingerprinting of systemic sclerosis: a systematic review
Victoria González, Daniel Galeano-Sánchez, Jaime Enrique Covaleda-Vargas, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 10

Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD
José M. Herranz, Amaya López-Pascual, Alex Clavería-Cabello, et al.
Journal of Physiology and Biochemistry (2023) Vol. 79, Iss. 4, pp. 901-924
Open Access | Times Cited: 10

Succinate-SUCNR1 induces renal tubular cell apoptosis
Min Pu, Jing Zhang, Yongcheng Zeng, et al.
AJP Cell Physiology (2023) Vol. 324, Iss. 2, pp. C467-C476
Closed Access | Times Cited: 9

Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis
Juan Li, Zhengcai Ma, Zhipeng Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 322, pp. 117600-117600
Closed Access | Times Cited: 9

LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver
Zhonghua Wang, Kenneth I. Zheng, Xiaodong Wang, et al.
Hepatobiliary & pancreatic diseases international (2021) Vol. 20, Iss. 5, pp. 452-459
Closed Access | Times Cited: 19

The pathogenic role of succinate-SUCNR1: a critical function that induces renal fibrosis via M2 macrophage
Min Pu, Jing Zhang, Fuyan Hong, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top